SCHEMBL3225293

SCHEMBL3225293

CC1CC(=O)C=C2CC[C@@H]3[C@H](CC[C@]4(C)[C@@H](O)CC[C@@H]34)[C@H]21

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SHBG P04278 7/20 0.65
▸ SERPINA6 P08185 4/20 0.65
▸ SLC22A1 O15245 1/20 0.65
▸ ALDH1A1 P00352 1/20 0.65
▸ THRB P10828 1/20 0.65
▸ AR P10275 5/20 0.58
▸ ESR2 Q92731 3/20 0.53
▸ ESR1 P03372 1/20 0.53
▸ PDK1 Q15118 2/20 0.51
▸ PDK2 Q15119 2/20 0.51
▸ PDK3 Q15120 2/20 0.51
▸ PDK4 Q16654 2/20 0.51
▸ CYP19A1 P11511 5/20 0.50
▸ LMNA P02545 3/20 0.50
▸ HSD17B10 Q99714 3/20 0.50
▸ NR3C1 P04150 2/20 0.50
▸ PGR P06401 2/20 0.50
▸ CYP3A4 P08684 2/20 0.50
▸ TSHR P16473 2/20 0.50
▸ SNCA P37840 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5550822 1.00 SHBG (0.65) SHBGSERPINA6SLC22A1ALDH1A1THRB
SCHEMBL3816340 0.90 SHBG (0.68) SHBGSERPINA6SLC22A1ALDH1A1THRB
SCHEMBL11647165 0.90 SHBG (0.68) SHBGSERPINA6SLC22A1ALDH1A1THRB
SCHEMBL11515579 0.90 SHBG (0.68) SHBGSERPINA6SLC22A1ALDH1A1THRB
SCHEMBL16741271 0.85 SERPINA6 (0.67) SHBGSERPINA6SLC22A1ALDH1A1THRB
SCHEMBL7705294 0.85 SHBG (0.61) SHBGSERPINA6SLC22A1ALDH1A1THRB
SCHEMBL29496903 0.85 SHBG (0.61) SHBGSERPINA6SLC22A1ALDH1A1THRB
SCHEMBL5552057 0.85 SHBG (0.61) SHBGSERPINA6SLC22A1ALDH1A1THRB
SCHEMBL12615681 0.84 SHBG (0.60) SHBGSERPINA6SLC22A1ALDH1A1THRB
SCHEMBL6007949 0.83 AR (0.71) SHBGSERPINA6SLC22A1ALDH1A1THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010008600-A1 TOPICAL DRUG DELIVERY SYSTEM DERMWORX INCORPORATED (US) 2010-01-21 — — WO disclosed
US-20090325911-A1 Use of Androgens for the Treatment of Parkinson's Disease CARITAS ST. ELIZABETH MEDICAL CENTER OF BOSTON, INC. 2009-12-31 — — US disclosed
WO-2007092350-A1 WOUND CARE ARTICLES, DRUG DELIVERY SYSTEMS AND METHODS OF USING THE SAME H.B. FULLER LICENSING & FINANCING, INC. (US) 2007-08-16 — — WO disclosed
WO-2007048034-A2 USE OF ANDROGENS FOR THE TREATMENT OF PARKINSON' S DISEASE CARITAS ST. ELIZABETH MEDICAL CENTER OF BOSTON, INC. (US) 2007-04-26 — — WO disclosed
EP-1747229-A1 STEROID PRODRUGS WITH ANDROGENIC EFFECT Schering Aktiengesellschaft (DE) 2007-01-31 — — EP disclosed
WO-2005113575-A1 STEROID PRODRUGS WITH ANDROGENIC EFFECT SCHERING AKTIENGESELLSCHAFT (DE) 2005-12-01 — — WO disclosed
EP-1556407-A2 PROCESS AND INTERMEDIATES TO PREPARE 17.BETA.-HYDROXY-7.ALFA.-METHYL-19-NOR-17.ALFA.-PREGN-5(10)-EN-20-YN-3-ONE INSTYTUT FARMACEUTYCZNY (PL) 2005-07-27 — — EP disclosed
EP-1523568-A2 MICROBIOLOGICAL METHOD FOR THE PRODUCTION OF 7 ALPHA-SUBSTITUTED 11 ALPHA-HYDROXYSTEROIDS Schering Aktiengesellschaft (DE) 2005-04-20 — — EP disclosed
WO-2004011663-A9 MICROBIOLOGICAL METHOD FOR THE PRODUCTION OF 7 ALPHA-SUBSTITUTED 11 ALPHA-HYDROXYSTEROIDS SCHERING AG (DE) 2004-05-06 — — WO disclosed
WO-2004031204-A2 PROCESS AND INTERMEDIATES TO PREPARE 17.BETA.-HYDROXY-7.ALFA.-METHYL-19-NOR-17.ALFA.-PREGN-5(10)-EN-20-YN-3-ONE INSTYTUT FARMACEUTYCZNY (PL) 2004-04-15 — — WO disclosed
WO-2004011663-A2 MICROBIOLOGICAL METHOD FOR THE PRODUCTION OF 7 ALPHA-SUBSTITUTED 11 ALPHA-HYDROXYSTEROIDS SCHERING AKTIENGESELLSCHAFT (DE) 2004-02-05 — — WO disclosed
WO-2003079961-A2 METHOD FOR PRODUCING 7$G(A)-METHYL STEROIDS SCHERING AKTIENGESELLSCHAFT (DE) 2003-10-02 — — WO disclosed
CN-1331585-A Spray on bandage and drug delivery system 3M INNOVATIVE PROPERTIES CO (US) 2002-01-16 — — CN disclosed
Send feedback